Study Summary
This trial is testing a new pain medication for people with cancer who haven't found relief from other treatments.
- Chronic Pain
- Pain
- Pain, Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: Baseline through study completion at up to approximately 12 months
Trial Safety
Phase-Based Safety
Trial Design
3 Treatment Groups
Concurrent Control
1 of 3
Resiniferatoxin
1 of 3
Placebo
1 of 3
Active Control
Experimental Treatment
Non-Treatment Group
120 Total Participants · 3 Treatment Groups
Primary Treatment: Resiniferatoxin · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Have other patients been studied in this way before?
"There are 4 ongoing clinical trials for Resiniferatoxin in 7 global cities and 1 nation. The original study, which was sponsored by Sorrento Therapeutics, Inc., had 45 patients and completed Phase 1 drug approval in 2009. To date, a total of 18292 trials have been conducted." - Anonymous Online Contributor
Could you please tell us if Resiniferatoxin has been researched before?
"Currently, 4 clinical trials are underway to study Resiniferatoxin. Of those active trials, 0 are in Phase 3. Although the majority of research is based out of Pasadena, California - where 11 different medical centres are running trials." - Anonymous Online Contributor
How many individuals are enrolling in this clinical trial?
"Yes, this trial is looking for enrollees as the information on clinicaltrials.gov indicates. The posting date was November 1st, 2022 with the most recent update happening on October 6th, 2022. They are hoping to find 120 patients total from a single site." - Anonymous Online Contributor
What are the dangers that come with Resiniferatoxin use?
"Resiniferatoxin falls into the category of a Phase 2 drug, meaning that while there is some evidence suggesting it is safe, there is none to support its efficacy. Our team at Power estimates its safety to be a 2 on our 3-point scale." - Anonymous Online Contributor
Is this a current opportunity for people to enroll in the trial?
"That is correct. The information available on clinicaltrials.gov verifies that this particular trial is looking for enrolment from patients. This data was initially posted on November 1st, 2020 and was most recently updated on October 6th, 2020. In total, the study requires 120 participants recruited from a single site." - Anonymous Online Contributor